日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Improved survival, disparate outcomes contemporaneously define the modern worldwide burden of childhood cancers

生存率的提高与治疗结果的差异,共同构成了当今全球儿童癌症负担的现状。

Kudek, Matthew R; Wang, Hao

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

Adenoviral Inciting Antigen and Somatic Hypermutation in VITT

腺病毒诱发抗原和体细胞高频突变在 VITT 中的作用

Wang, Jing Jing; Schönborn, Linda; Warkentin, Theodore E; Müller, Luisa; Thiele, Thomas; Ulm, Lena; Völker, Uwe; Ameling, Sabine; Franzenburg, Sören; Kaderali, Lars; Tzvetkova, Ana; Colella, Alex; Chataway, Tim; Tan, Chee Wee; Armour, Bridie; Troelnikov, Alexander; Rutten, Lucy; McCluskey, James; Zahn, Roland; Gordon, Tom P; Greinacher, Andreas

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies

MTAP缺失在癌基因驱动的非小细胞肺癌中很常见,并可能使肿瘤对PRMT5抑制剂和靶向治疗联合治疗敏感。

Aldea, M; Lenahan, S; Locquet, M-A; Liao, L; Gasparro, M; Gokhale, P C; Ghigna, M-R; Ionescu, D N; Odintsov, I; Ngo, K; Wang, X; Aziz, S; Pecci, F; Garbo, E; Ivanova, E; Nakazawa, S; Kulesza, J; Tsai, J A; Zullo, L; Lee, J; Zielinska, M; Simon, S; Han, D; Marinello, A; Li, G; Rossato de Almeida, G; Huang, J; Paoloni, F; Gariazzo, E; Santo, V; Remon, J; Marks, J A; LoPiccolo, J; Florez, N; Nishino, M; Ricciuti, B; Luo, J; Barbie, D A; Planchard, D; Rotow, J K; Barlesi, F; Graf, R P; Feng, W W; Besse, B; Paweletz, C; Sholl, L; Shaw, A T; Jänne, P A

MALDI Matrix: Origins, Innovations, and Frontiers

MALDI矩阵:起源、创新与前沿

Wu, Ran; Liu, Rui; Hu, Hao; Qin, Liang; Chen, Lulu; Bao, Zhibin; Fu, Jinxiang; Guo, Hua; Wang, Lei; Wang, Anna; Wang, Zihan; Yang, Chenyu; Cheng, Xiangrui; Chen, Difan; Liu, Haiqiang; Jing, Yanping; Guo, Shuai; Fu, Yujie; Wang, Xiaodong

Beyond the Sequence: Chemical and Topological Design and Innovations in mRNA Therapeutics

超越序列:mRNA疗法的化学和拓扑设计与创新

Liu, Dangliang; Chen, Hongyu; Pan, Alisia; Wang, Xiao

Donation After Circulatory Death Heart Transplant Without Preimplant Reanimation Using Rapid Ultraoxygenated Recovery

循环死亡后捐献心脏移植,无需术前复苏,采用快速超氧恢复技术

Williams, Aaron M; Trahanas, John; Bommareddi, Swaroop; McGann, Kevin C; Ahmad, Awab; Lima, Brian; Wang, Chen Chia; Petrovic, Mark; Devries, Stephen; Lowman, Joshua; Absi, Tarek; Quintana, Eric; Siddiqi, Hasan; Amancherla, Kaushik; Brinkley, Marshall; Tsai, Stacy; Menachem, Jonathan N; Pedrotty, Dawn; Rali, Aniket S; Sacks, Suzanne; Zalawadiya, Sandip; Lepore, Joey; Pretorius, Mias; Schlendorf, Kelly; Bacchetta, Matthew; Shah, Ashish S

Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity

针对A型血友病的I期试点研究:AAV8载体联合预防性他克莫司-糖皮质激素治疗可达到治疗性FVIII活性。

Liu, Wei; Pei, Xiaolei; Yu, Tenghui; Xu, Bingqi; Dai, Xinyue; Xue, Feng; Chen, Lingling; Wang, Xiaolin; Wang, Yuhua; Chen, Yunfei; Liu, Xiaofan; Fu, Rongfeng; Wang, Wentian; Chi, Ying; Li, Hui Yuan; Yang, Renchi; Zhang, Lei